Advertisement

Tumor-M2-Pyruvatkinase

  • S. HoldenriederEmail author
  • P. Stieber
Chapter
Part of the Springer Reference Medizin book series (SRM)

Literatur

  1. Diamandis E, Fritsche HA, Lilja H et al (2002) Tumor markers. Physiology, pathobiology, technology, and clinical applications, 1. Aufl. AACC Press, Washington, DCGoogle Scholar
  2. Hardt PD, Mazurek S, Toepler M et al (2004) Faecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancer. Br J Cancer 91:980–984CrossRefPubMedPubMedCentralGoogle Scholar
  3. Haug U, Hundt S, Brenner H (2008) Sensitivity and specificity of faecal tumour M2 pyruvate kinase for detection of colorectal adenomas in a large screening study. British Journal of Cancer 99 (1):133–135Google Scholar
  4. Yogesh MS, Stefan L, Nicolas H, Nada P, Ernst H, Wolfgang R, Joachim M, Jürgen MS (2008) Comparison of an Established Simple Office-Based Immunological FOBT With Fecal Tumor Pyruvate Kinase Type M2 (M2-PK) for Colorectal Cancer Screening: Prospective Multicenter Study. The American Journal of Gastroenterology 103 (6):1496–1504Google Scholar

Copyright information

© Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature 2019

Authors and Affiliations

  1. 1.Institut für Laboratoriumsmedizin, Deutsches Herzzentrum MünchenKlinik an der Technischen Universität MünchenMünchenDeutschland
  2. 2.Institut für LaboratoriumsmedizinKlinikum der Universität München (LMU)MünchenDeutschland

Personalised recommendations